Veru VERU
NASDAQ VERU
$2.48 -0.10 (-3.87%)
As of: Sep 9, 2026 · 3:59 PM EDT

Veru (VERU) Non Operating Interest Expenses (2014 - 2024)

Veru's (VERU) quarterly Non Operating Interest Expenses came in at $169867.0 in Q3 2024, down 18.02% year-over-year from $207201.0 in Q4 2023, and up 33.4% quarter-over-quarter from $127336.0 in Q2 2024.

Analysis

Veru (VERU) Non Operating Interest Expenses (2014 - 2024) Analysis & Trends

Veru (VERU) has reported Non Operating Interest Expenses for 9 consecutive years, with $169867.0 the latest figure, recorded in Q3 2024.

  • On a quarterly basis, Non Operating Interest Expenses fell 18.02% year-over-year to $169867.0 in Q3 2024; TTM through Sep 2024 was $607470.0, a 74.97% decrease from a year earlier, with the FY2024 full-year figure at $607470.0, down 74.97% from the prior year.
  • Non Operating Interest Expenses was $169867.0 for Q3 2024 at Veru, up from $127336.0 in the prior quarter.
  • Over five years, Non Operating Interest Expenses peaked at $1.3 million in Q2 2021 and troughed at $127336.0 in Q2 2024.
  • A 5-year average of $829966.3 and a median of $1.1 million in 2020 frame the typical range for Non Operating Interest Expenses.
  • Across the five-year window, Non Operating Interest Expenses advanced 10.07% in 2021 and sank 81.11% in 2023, its largest moves.
  • Over 5 years, Non Operating Interest Expenses stood at $1.2 million in 2020, then fell by 2.56% to $1.2 million in 2021, then declined by 24.64% to $873230.0 in 2022, then slumped by 81.11% to $164957.0 in 2023, then advanced by 2.98% to $169867.0 in 2024.
  • The last three Non Operating Interest Expenses figures came in at $169867.0 (Q3 2024), $127336.0 (Q2 2024), and $145310.0 (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 281.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 23.78 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 2.90 Mn
10 Veru 57.86 Mn 32.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 169,867.00
Jun 30, 2024 127,336.00
Mar 31, 2024 145,310.00
Dec 31, 2023 164,957.00
Sep 30, 2023 207,201.00
Jun 30, 2023 648,917.00
Mar 31, 2023 697,693.00
Dec 31, 2022 873,230.00
Sep 30, 2022 812,321.00
Jun 30, 2022 1.19 Mn
Mar 31, 2022 1.21 Mn
Dec 31, 2021 1.16 Mn
Sep 30, 2021 1.16 Mn
Jun 30, 2021 1.29 Mn
Mar 31, 2021 1.25 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 1.15 Mn
Jun 30, 2020 1.17 Mn
Mar 31, 2020 1.16 Mn
Dec 31, 2019 1.14 Mn